September 30th, 2023

Some of the companies expected to report financial results on Wednesday, October 4, are: Tilray Brands, Inc. (Nasdaq: TLRY), a company in the cannabis industry, is scheduled to release its first-quarter fiscal 2024 financial results before the mar. Read more

September 30th, 2023

Here are some companies set to report their financial results on Wednesday, October 4: RPM International Inc. (NYSE: RPM), a global leader in specialty coatings and sealants, is scheduled to release its fiscal 2024 first-quarter financial results . Read more

September 30th, 2023

SmileDirectClub, Inc. (Nasdaq: SDC) has unveiled plans for a significant recapitalization effort, aimed at fortifying the company's financial foundation and supporting future growth as a global leader in oral care. The recapitalization will involv. Read more

September 29th, 2023

Shares of OpGen, Inc. (Nasdaq: OPGN) surged by more than 100% in pre-market trading following a regulatory filing with the Securities and Exchange Commission (SEC), requesting the SEC's consent to withdraw the company's Registration Statement on Form. Read more

September 29th, 2023

The Competition and Markets Authority (CMA) has given the green light to the £1.2 billion acquisition deal between healthcare tech companies UnitedHealth Group Inc. (NYSE: UNH) and EMIS, both of which provide critical services to the UK's Natio. Read more

September 29th, 2023

Shares of Novo Integrated Sciences, Inc. (Nasdaq: NVOS) surged by more than 100% in after-hours trading following the company's announcement of a significant development. Novo and Blacksheep Trust have finalized a One Billion Dollar Master Collateral. Read more

September 28th, 2023

NIKE, Inc. (NYSE: NKE), a prominent sportswear and athletic equipment company, reported first-quarter fiscal 2024 earnings of $0.94 per share, surpassing the consensus EPS estimate of $0.74. Quarterly revenues for the company amounted to $12.9 billio. Read more

September 28th, 2023

BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI), a biotechnology company that specializes in developing innovative stem cell therapies for neurodegenerative diseases, faced a setback as the U.S. Food and Drug Administration's Cellular, Tissue, and G. Read more

September 28th, 2023

Shares of Gritstone bio, Inc. (Nasdaq: GRTS) soared over 40% in after-hours trading  following the company's announcement of an up to $433 million contract awarded by the Biomedical Advanced Research and Development Authority (BARDA). The contra. Read more

September 27th, 2023

Micron Technology, Inc. (Nasdaq: MU), a renowned semiconductor company, reported a loss of $(1.07) per share for the fourth quarter of fiscal 2023, better than the consensus estimate loss of $(1.18). The company's quarterly revenues reached $4.01 bil. Read more